Bullish option flow detected in Bristol Myers ( BMY) Squibb with 17,811 calls trading, 1.1x expected, and implied vol increasing over 2 points to 28.33%. May-25 60 calls and 3/14 weekly 63 calls are ...

Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...

Around the same time, the prototype of the Squibb logo was designed. The logo represented product uniformity, purity, efficacy and reliability based on research. By 1924, Bristol-Myers' gross ...

2seventy bio, Inc. (Nasdaq: TSVT), today announced a definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY ... “The strategic rationale for this acquisition is clear and ...

Bristol Myers Squibb (BMS) has shared positive five-year results from ... and 52.6% achieved Physician’s Global Assessment scores of zero or one (clear/almost clear skin) after five years compared to ...

Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To clear competition hurdles surrounding the merger, Celgene sold the Otezla franchise to Amgen for $13.4 billion. With pair of trial wins in psoriatic arthritis, Bristol Myers Squibb looks to ...

“The strategic rationale for this acquisition is clear and today’s announcement ... available at www.AbecmaREMS.com or contact Bristol-Myers Squibb at 1-866-340-7332. Hypersensitivity ...

K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.